| Name | 3-Fluoro-4-{[hydroxy(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-nap hthalenyl)acetyl]amino}benzoic acid |
|---|
| Description | BMS961 is a selective retinoic acid receptor-γ (RARγ) agonist. BMS961 shows anti-inflammatory activity[1]. |
|---|---|
| Related Catalog | |
| Target |
RARγ |
| In Vitro | BMS961 inhibits the expression of Dectin-1 and pro-inflammatory cytokines[1]. |
| References |
| Molecular Formula | C23H26FNO4 |
|---|---|
| Molecular Weight | 399.45500 |
| Exact Mass | 399.18500 |
| PSA | 90.12000 |
| LogP | 5.19450 |